A meta-analysis of randomized controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer

Breast J. 2011 Jan-Feb;17(1):109-11. doi: 10.1111/j.1524-4741.2010.01034.x. Epub 2010 Dec 6.

Authors

Cun Liao¹, Fang Yin, Ping Huang, Yunfei Cao, Feng Gao

Affiliation

¹ Department of Colorectal and Anal Surgery, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.

PMID: 21129096
DOI: 10.1111/j.1524-4741.2010.01034.x

No abstract available

Publication types

Letter
Meta-Analysis
Review

MeSH terms

Anemia / chemically induced
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / metabolism
Female
Humans
Neutropenia / chemically induced
Randomized Controlled Trials as Topic*
Receptor, ErbB-2 / metabolism
Stroke Volume / drug effects
Trastuzumab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
ERBB2 protein, human
Receptor, ErbB-2
Trastuzumab